Skip to content

Pulmonary Care and Research Collaborative Patient Registry

Pulmonary Care and Research Collaborative Patient Registry

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05445817
Enrollment
150
Registered
2022-07-06
Start date
2022-07-31
Completion date
2024-03-31
Last updated
2022-07-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Interstitial Lung Disease

Keywords

Progressive Fibrosing Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease Associated With Systemic Sclerosis, Myositis-Associated Interstitial Lung Disease, Sarcoidosis, Hypersensitivity Pneumonitis, Pulmonary Fibrosis

Brief summary

The purpose of this research study is to build and maintain a registry of people with interstitial lung disease (ILD). Medical information collected for this registry may be used to advance ILD and pulmonary research and improve patient care. This is an observational registry. Participants will not receive any investigational treatments or investigational drugs as part of their participation in this registry.

Detailed description

The registry will contain longitudinal medical histories of ILD patients. The creation and curation of the registry with utilize release of information services, biomedical informatics methods and human expert reviews. Among the registry's long-term goals is to utilize its data and informatics resources to study and advance ILD diagnosis and treatment. The registry will be developed with a set of capabilities to consistently, repeatedly, and economically build research-grade datasets that allow cohort development from natively unstructured and non-standard phenotypic clinical and imaging data.

Interventions

None listed

Sponsors

Genentech, Inc.
CollaboratorINDUSTRY
Pulmonary Care and Research Collaborative Limited
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* People with a confirmed diagnosis of interstitial lung disease by a primary care physician and/or pulmonologist.

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frame
Development and implementation of a database populated with de-identified longitudinal medical histories of interstitial lung disease patients.Up to 18 months

Secondary

MeasureTime frame
Advancing the understanding of the natural course and the treatments of interstitial lung diseases.Up to 18 months

Countries

United States

Contacts

Primary ContactAliaa Barakat, PhD
aliaa.barakat@ildcollaborative.org617-895-6636
Backup ContactArthur Dea, BA
arthur.dea@ildcollaborative.org617-895-9879

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026